Albemarle Corp., US0126531013

Albemarle stock rebounds as lithium pricing lifts third-quarter profit

Published on 11/12/2026 at 01:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Albemarle stock traded at 86.74 euros in late trading on Wednesday. The lithium producer reported a sharp rebound in third-quarter profitability.

Stronger quarter, softer near-term outlook

  • Albemarle returned to quarterly profitability as lithium pricing improved.
  • Management raised its full-year Specialties EBITDA outlook and lowered planned capital spending.
  • Fourth-quarter Energy Storage results are expected to decline sequentially amid softer pricing and higher-cost inventory.
Albemarle Corp., US0126531013, Illustration mit AI erstellt.

Albemarle reported a sharp improvement in its third-quarter results on November 4, as higher lithium pricing and productivity gains lifted earnings. The company said Albemarle generated net sales of 1.6 billion US dollars in the quarter ended September 30, up 19 percent from a year earlier.

Adjusted EBITDA rose 186 percent to 646 million US dollars. Net income reached 297 million US dollars, or 2.15 US dollars per diluted share, while adjusted earnings were 2.58 US dollars per share. The adjusted figures primarily exclude restructuring and related charges.

Lithium pricing drives recovery

Energy Storage was the main earnings engine. Higher lithium prices lifted the segment, while Specialties benefited from both pricing and volume gains. Albemarle also reported more than 150 million US dollars in year-to-date run-rate cost and productivity improvements, reaching the upper end of its full-year target.

Management raised its full-year adjusted EBITDA outlook for Specialties to 350 million to 375 million US dollars from a previous range of 275 million to 325 million US dollars. Capital expenditure is now expected at 300 million to 350 million US dollars, below the earlier plan of roughly 500 million US dollars.

Fourth-quarter pressure remains

Albemarle expects Energy Storage sales and adjusted EBITDA to decline sequentially in the fourth quarter. Softer market pricing and higher-cost spodumene inventory moving through the production system are expected to weigh on margins. The outlook leaves the company with stronger year-on-year earnings momentum but a more difficult near-term comparison.

Albemarle stock traded at 86.74 euros on Lang & Schwarz at 11:00 p.m. CET on Wednesday, November 11. The quote was below the previous Lang & Schwarz close of 87.07 euros.

Albemarle's business and market position

Albemarle is headquartered in Charlotte, North Carolina, and supplies specialty chemicals and lithium products for mobility, energy, connectivity and health markets. Its activities span Energy Storage and Specialties, including lithium and bromine-related products. This mix gives the company exposure to battery materials as well as specialty-chemical applications, rather than a single product market.

Albemarle Corporation at a glance

  • Company: Albemarle Corporation
  • ISIN: US0126531013
  • Primary listing: New York Stock Exchange
  • Late-trading quote: 86.74 euros on Lang & Schwarz, Wednesday, November 11, 2026, 11:00 p.m. CET
  • Previous Lang & Schwarz close: 87.07 euros
  • Third-quarter net sales: 1.6 billion US dollars, up 19 percent year over year
  • Third-quarter adjusted EBITDA: 646 million US dollars, up 186 percent year over year

US equities remain the relevant market backdrop for the company, with current S&P 500 market reports providing the broader index context.

More news and analyses on Albemarle stock

Disclaimer...
en | US0126531013 | ALBEMARLE CORP. | boerse | 70494505 | bgmi